<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/869F0B29-11C9-4722-9E9E-205F6BC4F56D"><gtr:id>869F0B29-11C9-4722-9E9E-205F6BC4F56D</gtr:id><gtr:name>Tecan UK Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/33735849-D455-4914-AB52-D4E0A8F67091"><gtr:id>33735849-D455-4914-AB52-D4E0A8F67091</gtr:id><gtr:name>Pluriomics BV</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/252189B3-135F-4D99-BFB7-0799A34A409C"><gtr:id>252189B3-135F-4D99-BFB7-0799A34A409C</gtr:id><gtr:name>Loughborough University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AD4088FA-6FCC-4FDB-ABBC-0CE9592F0B75"><gtr:id>AD4088FA-6FCC-4FDB-ABBC-0CE9592F0B75</gtr:id><gtr:name>Centre for Life</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A400BE25-0A67-4DC4-90E2-F3C57C400F4D"><gtr:id>A400BE25-0A67-4DC4-90E2-F3C57C400F4D</gtr:id><gtr:name>Technion Israel Institue of Technology</gtr:name><gtr:address><gtr:line1>Taub Building</gtr:line1><gtr:line2>Technion  Institute of Technology</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/BC0E951E-239C-4369-8E5A-6E82F9B06B50"><gtr:id>BC0E951E-239C-4369-8E5A-6E82F9B06B50</gtr:id><gtr:name>University of Leiden</gtr:name><gtr:address><gtr:line1>P.O. Box 9506</gtr:line1><gtr:line4>Leiden</gtr:line4><gtr:line5>2300</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/42B56A32-9194-468C-A790-BE55133838A6"><gtr:id>42B56A32-9194-468C-A790-BE55133838A6</gtr:id><gtr:name>University of Hamburg</gtr:name><gtr:address><gtr:line1>ZMK</gtr:line1><gtr:line2>Blunderstrasse</gtr:line2><gtr:line4>Hamburg</gtr:line4><gtr:line5>20146</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/00FE3D00-46A6-4EDB-9672-1565C1E10DB8"><gtr:id>00FE3D00-46A6-4EDB-9672-1565C1E10DB8</gtr:id><gtr:name>Massachusetts Institute of Technology</gtr:name><gtr:address><gtr:line1>77 Massachusetts Avenue</gtr:line1><gtr:postCode>02139</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AA6E6E03-A703-45C0-8978-64589E5CECD4"><gtr:id>AA6E6E03-A703-45C0-8978-64589E5CECD4</gtr:id><gtr:name>University of A Coruna</gtr:name><gtr:address><gtr:line1>Campus da Zapateira</gtr:line1><gtr:line2>9 calle maestranza</gtr:line2><gtr:postCode>15001</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A0164CD1-D64C-4811-88B8-67B800E02651"><gtr:id>A0164CD1-D64C-4811-88B8-67B800E02651</gtr:id><gtr:name>Tokyo Electron</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9D53091E-603E-4B64-B5EC-6430D28827FD"><gtr:id>9D53091E-603E-4B64-B5EC-6430D28827FD</gtr:id><gtr:name>Syngenta</gtr:name><gtr:address><gtr:line1>WRO-1004.1.51</gtr:line1><gtr:line2>Schwarzwaldallee 215</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>School of Human Development</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/869F0B29-11C9-4722-9E9E-205F6BC4F56D"><gtr:id>869F0B29-11C9-4722-9E9E-205F6BC4F56D</gtr:id><gtr:name>Tecan UK Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/33735849-D455-4914-AB52-D4E0A8F67091"><gtr:id>33735849-D455-4914-AB52-D4E0A8F67091</gtr:id><gtr:name>Pluriomics BV</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/252189B3-135F-4D99-BFB7-0799A34A409C"><gtr:id>252189B3-135F-4D99-BFB7-0799A34A409C</gtr:id><gtr:name>Loughborough University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AD4088FA-6FCC-4FDB-ABBC-0CE9592F0B75"><gtr:id>AD4088FA-6FCC-4FDB-ABBC-0CE9592F0B75</gtr:id><gtr:name>Centre for Life</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A400BE25-0A67-4DC4-90E2-F3C57C400F4D"><gtr:id>A400BE25-0A67-4DC4-90E2-F3C57C400F4D</gtr:id><gtr:name>Technion Israel Institue of Technology</gtr:name><gtr:address><gtr:line1>Taub Building</gtr:line1><gtr:line2>Technion  Institute of Technology</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/BC0E951E-239C-4369-8E5A-6E82F9B06B50"><gtr:id>BC0E951E-239C-4369-8E5A-6E82F9B06B50</gtr:id><gtr:name>University of Leiden</gtr:name><gtr:address><gtr:line1>P.O. Box 9506</gtr:line1><gtr:line4>Leiden</gtr:line4><gtr:line5>2300</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/42B56A32-9194-468C-A790-BE55133838A6"><gtr:id>42B56A32-9194-468C-A790-BE55133838A6</gtr:id><gtr:name>University of Hamburg</gtr:name><gtr:address><gtr:line1>ZMK</gtr:line1><gtr:line2>Blunderstrasse</gtr:line2><gtr:line4>Hamburg</gtr:line4><gtr:line5>20146</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/00FE3D00-46A6-4EDB-9672-1565C1E10DB8"><gtr:id>00FE3D00-46A6-4EDB-9672-1565C1E10DB8</gtr:id><gtr:name>Massachusetts Institute of Technology</gtr:name><gtr:address><gtr:line1>77 Massachusetts Avenue</gtr:line1><gtr:postCode>02139</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AA6E6E03-A703-45C0-8978-64589E5CECD4"><gtr:id>AA6E6E03-A703-45C0-8978-64589E5CECD4</gtr:id><gtr:name>University of A Coruna</gtr:name><gtr:address><gtr:line1>Campus da Zapateira</gtr:line1><gtr:line2>9 calle maestranza</gtr:line2><gtr:postCode>15001</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A0164CD1-D64C-4811-88B8-67B800E02651"><gtr:id>A0164CD1-D64C-4811-88B8-67B800E02651</gtr:id><gtr:name>Tokyo Electron</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9D53091E-603E-4B64-B5EC-6430D28827FD"><gtr:id>9D53091E-603E-4B64-B5EC-6430D28827FD</gtr:id><gtr:name>Syngenta</gtr:name><gtr:address><gtr:line1>WRO-1004.1.51</gtr:line1><gtr:line2>Schwarzwaldallee 215</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6D93C4B4-6A1A-4858-8A69-03438AAFF1FC"><gtr:id>6D93C4B4-6A1A-4858-8A69-03438AAFF1FC</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Denning</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/06E9C900-A07E-4D04-A0C3-0DF79EA9BB4E"><gtr:id>06E9C900-A07E-4D04-A0C3-0DF79EA9BB4E</gtr:id><gtr:firstName>HKM</gtr:firstName><gtr:surname>Lochmuller</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/12776B47-8A7E-42A7-89AF-B9DDF6A4E701"><gtr:id>12776B47-8A7E-42A7-89AF-B9DDF6A4E701</gtr:id><gtr:firstName>Voker</gtr:firstName><gtr:surname>Straub</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0801098"><gtr:id>0D5E8AA8-0018-49CC-B797-9203ADA4717A</gtr:id><gtr:title>New in vitro models of DMD by induced pluripotency in patient biopsies and gene knockdown in hESCs</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801098</gtr:grantReference><gtr:abstractText>Duchenne muscular dystrophy (DMD) is a genetic disorder that ultimately leads to the death of 1 in every 3,000 newborn males. Boys become wheelchair bound in their early teens and succumb to the condition in their twenties to thirties. Heart failure is a major cause of fatality and there is no cure. Years of research have identified the gene that causes DMD and the effects on patients? health have been widely documented. However, the basic understanding of how the condition affects the cells as humans grow and develop is not well understood, particularly in organs such as the heart. In part, our lack of understanding is because we cannot examine the detailed processes that go on either in the cells of young DMD patients or in the cells of their hearts. 
This grant application is aimed at combining the knowledge of researchers at the University of Nottingham, who have expertise in human embryonic stem cell (hESC) and induced pluripotent stem cell (iPSC) biology, and those at the University of Newcastle, who have clinical and research experience in studying DMD and how it affects function of muscle cells. Combining these sources of expertise will provide new ways to study DMD and in the future it is hoped that this will lead to new treatments. How will this be achieved? 
Whereas hESCs are derived from embryos given by consenting couples undergoing fertility treatment, iPSCs are produced by treating skin cells special proteins. This means that hESCs grown in the laboratory can be made to carry the mutations found in patients with DMD. Alternatively, skin cells from DMD patients can be converted into iPSCs that carry the patient-specific mutation. Remarkably, both hESCs and iPSCs can be grown in a plastic dish in the lab and made to mimic a very early stage of human development, including formation of beating heart cells (cardiomyocytes). This provides a way for the effect of the mutations that cause DMD on early development and cardiomyocyte function to be studied in a carefully controlled laboratory setting. The benefit of this is two-fold. First, it will provide a clearer understanding of the disease process. Second, it will provide a lab-based system that can be used in the future to test new drugs for alleviation and treatment of the symptoms of DMD that affect the heart.</gtr:abstractText><gtr:technicalSummary>The prevalence of Duchenne muscular dystrophy (DMD) is ~1 in 3,000 in newborn males and all die as young adults, usually in their twenties to thirties. Although heart failure accounts for at least 25% of fatalities, little is known about how the disorder affects development or function of human cardiomyocytes. Limited knowledge arises from lack of DMD cardiac biopsies, mouse models that show only mild heart anomalies and a complex causative DMD gene, which encodes many dystrophin isoforms. In this proposal we will exploit our wealth of knowledge of culture, genetic modification and cardiomyocyte differentiation of hESCs to produce transgenic lines in which variable numbers of the dystrophin isoforms are knocked down by RNAi. In parallel, we will extend our initial work in which pluripotency has been induced in fibroblasts by lentiviral transduction of transcription factors to now reprogramme fibroblasts from DMD patients. These cellular resources will be used to evaluate the effect of perturbed dystrophin expression on structure and location of the dystrophin-glycoprotein complex (DGC) during differentiation, as well as the impact on cardiomyocyte development, function, survival and electrophysiology. Development of this platform will have far-reaching applications for in vitro modelling of numerous genetic disorders of the heart, providing new routes to innovate and test intervention strategies.</gtr:technicalSummary><gtr:fund><gtr:end>2012-09-08</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-03-09</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>445880</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC-TEL consortium (Manchester, UKSCB, Sanger, TEL)</gtr:description><gtr:id>639FA221-DEF5-4D39-91F4-EA1AFC3472E5</gtr:id><gtr:impact>joint grant with industrial partner</gtr:impact><gtr:partnerContribution>joint grant with industrial partner</gtr:partnerContribution><gtr:piContribution>joint grant with industrial partner</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London (QMUL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Queen Mary College</gtr:department><gtr:description>Electrophysiology mechanisms (Harmer / Tinker)</gtr:description><gtr:id>9620D32E-41BA-4CC5-AF66-809DB3846331</gtr:id><gtr:impact>grants awarded. Papers in progress</gtr:impact><gtr:partnerContribution>Skills in detailed electrophyioslogy</gtr:partnerContribution><gtr:piContribution>mechanism of electrophysiology in hPSC-cardiomyocytes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pluriomics BV</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Sharing hiPSC lines (Pluriomics)</gtr:description><gtr:id>DD82A614-2FCD-4992-90D3-2537A41B1B99</gtr:id><gtr:impact>Braam SR, Tertoolen L, Casini S, Matsa E, Lu HR, Teisman A, Passier R, Denning C, Gallacher DJ, Towart R, Mummery CL. (2012) Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes. Stem Cell Research. 10(1):48-56. PMID: 23089628</gtr:impact><gtr:partnerContribution>Used our resources and input to carry out project</gtr:partnerContribution><gtr:piContribution>Provision of hiPSC lines, intellectual input to project</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Safety Assessment GSK</gtr:department><gtr:description>CRACK-IT consortium</gtr:description><gtr:id>BB15E294-F2C9-4ABC-86EA-283F4B838E77</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:partnerContribution>all active contributors to researcher and academic input</gtr:partnerContribution><gtr:piContribution>consortium working on safety assessment</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Clinical Sciences Nottingham</gtr:department><gtr:description>LQT (Staniforth)</gtr:description><gtr:id>35F5D8D5-9210-4BAC-839B-DD59223D5816</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:partnerContribution>publications</gtr:partnerContribution><gtr:piContribution>led collab</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Syngenta</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>syngenta</gtr:description><gtr:id>46FBC159-0A0C-47F9-BD9D-9979CF24371D</gtr:id><gtr:impact>advances in stem cell automation</gtr:impact><gtr:partnerContribution>intellectual and financial input</gtr:partnerContribution><gtr:piContribution>stem cell automation</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tecan UK Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Automation (Development of robot)</gtr:description><gtr:id>AA970C6C-CECA-443A-BFAE-F8ED77C94512</gtr:id><gtr:impact>Publications, grants</gtr:impact><gtr:partnerContribution>Role in automation</gtr:partnerContribution><gtr:piContribution>Bespoke robotic platform for automated culture and differentiation of human stem cells</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leiden University</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>exon skipping (Leiden, Aartsma-Rus)</gtr:description><gtr:id>864A605D-8AC6-4EFE-B5AE-676E7C1C8253</gtr:id><gtr:impact>Publication of paper</gtr:impact><gtr:partnerContribution>reagents and expertise in exon skipping</gtr:partnerContribution><gtr:piContribution>brought skills to the team not available in Nottingham</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centre for Life</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DMD (Lochmuller)</gtr:description><gtr:id>D1BFAD17-53AA-470C-9806-A1A55AE38B07</gtr:id><gtr:impact>grants &amp;amp; publications</gtr:impact><gtr:partnerContribution>publications &amp;amp; grant</gtr:partnerContribution><gtr:piContribution>led research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC-TEL consortium (Manchester, UKSCB, Sanger, TEL)</gtr:description><gtr:id>7D4D1DF9-A1EA-42D4-A2A8-F1BB60FB592F</gtr:id><gtr:impact>joint grant with industrial partner</gtr:impact><gtr:partnerContribution>joint grant with industrial partner</gtr:partnerContribution><gtr:piContribution>joint grant with industrial partner</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Safety Assessment GSK</gtr:department><gtr:description>Industrial collaboration (GSK via CRACK-IT)</gtr:description><gtr:id>C394D694-BED5-4E48-B60B-E7C22D00B59F</gtr:id><gtr:impact>Financial, international collaboration, skills sharing, joint PhD students, researcher exchange</gtr:impact><gtr:partnerContribution>Implicit in the sponsorship and construction of the challenge</gtr:partnerContribution><gtr:piContribution>Facilitated award of NC3Rs CRACK-IT grant</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Maturation grant (Tinker, Smith, Fischer)</gtr:description><gtr:id>A0D5C8BF-3123-49B5-9B9E-2EB3DBA3B34C</gtr:id><gtr:impact>joint grant and development of equipment, new molecules, cell resources</gtr:impact><gtr:partnerContribution>joint grant and development of equipment, new molecules, cell resources</gtr:partnerContribution><gtr:piContribution>joint grant and development of equipment, new molecules, cell resources</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London (QMUL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Queen Mary College</gtr:department><gtr:description>Maturation grant (Tinker, Smith, Fischer)</gtr:description><gtr:id>E9B31A1A-1CBC-4474-893D-6C4E9D059771</gtr:id><gtr:impact>joint grant and development of equipment, new molecules, cell resources</gtr:impact><gtr:partnerContribution>joint grant and development of equipment, new molecules, cell resources</gtr:partnerContribution><gtr:piContribution>joint grant and development of equipment, new molecules, cell resources</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Hamburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>CRACK-IT consortium</gtr:description><gtr:id>E16F828B-509A-4879-BC95-5E4552E3D7CA</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:partnerContribution>all active contributors to researcher and academic input</gtr:partnerContribution><gtr:piContribution>consortium working on safety assessment</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London (KCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>virus (Dave Darling)</gtr:description><gtr:id>AB521C78-F236-449B-99ED-8AF6C5011B08</gtr:id><gtr:impact>publications</gtr:impact><gtr:partnerContribution>publications</gtr:partnerContribution><gtr:piContribution>led collab</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Institute for Biological Standards and Control (NIBSC)</gtr:department><gtr:description>MRC-TEL consortium (Manchester, UKSCB, Sanger, TEL)</gtr:description><gtr:id>F0C8BC5A-4093-4513-B5BF-55C56301786D</gtr:id><gtr:impact>joint grant with industrial partner</gtr:impact><gtr:partnerContribution>joint grant with industrial partner</gtr:partnerContribution><gtr:piContribution>joint grant with industrial partner</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>electrophysiology (CPVT, George / Williams)</gtr:description><gtr:id>972CE818-87F6-454E-A272-C25E7B0D8D57</gtr:id><gtr:impact>Grant secured. Working towards papers</gtr:impact><gtr:partnerContribution>Developed to &amp;pound;1.1m BHF grant</gtr:partnerContribution><gtr:piContribution>electrophysiology of cardiomyocytes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Loughborough University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Engineering</gtr:department><gtr:description>BRIC - Loughborough</gtr:description><gtr:id>39BBD267-9965-440B-A372-D5931DC37F32</gtr:id><gtr:impact>publications</gtr:impact><gtr:piContribution>Research collaboration to secure funds</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Imperial (Sian Harding)</gtr:description><gtr:id>281CE905-74C0-46AE-A7C1-925CA6F92ED5</gtr:id><gtr:impact>multiple activities on grants, papers, sharing skills, reagents etc</gtr:impact><gtr:partnerContribution>multiple activities on grants, papers, sharing skills, reagents etc</gtr:partnerContribution><gtr:piContribution>multiple activities on grants, papers, sharing skills, reagents etc</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DM1 grant &amp;amp; activity (Lochmuller)</gtr:description><gtr:id>FA66C35E-B5E5-4FA1-97DF-A6524BBFC2F6</gtr:id><gtr:impact>Joint grant, hence economic</gtr:impact><gtr:partnerContribution>Academic collaboration; joint posts; sharing of reagents and data</gtr:partnerContribution><gtr:piContribution>Joint BHF grant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy Nottingham</gtr:department><gtr:description>surface work (Morgan Alexander, Nottingham)</gtr:description><gtr:id>B7B6066D-8807-4304-9368-9C7C328428CE</gtr:id><gtr:impact>grants and papers</gtr:impact><gtr:partnerContribution>Multiple grant awards and papers</gtr:partnerContribution><gtr:piContribution>lead the stem cell work of this collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leiden University</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>CRACK-IT consortium</gtr:description><gtr:id>D22E14CC-B932-4128-A646-5340B00E9788</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:partnerContribution>all active contributors to researcher and academic input</gtr:partnerContribution><gtr:piContribution>consortium working on safety assessment</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tokyo Electron</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>MRC-TEL consortium (Manchester, UKSCB, Sanger, TEL)</gtr:description><gtr:id>16A2229C-7DB3-421A-A6A5-BA91AA278119</gtr:id><gtr:impact>joint grant with industrial partner</gtr:impact><gtr:partnerContribution>joint grant with industrial partner</gtr:partnerContribution><gtr:piContribution>joint grant with industrial partner</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of A Coru?a</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Spannish patients (Roberto Barriales-Villa)</gtr:description><gtr:id>2B86194E-2A70-4914-8DEB-AC447B7CBB26</gtr:id><gtr:impact>provision of patient samples to underpin research</gtr:impact><gtr:partnerContribution>provision of patient samples to underpin research</gtr:partnerContribution><gtr:piContribution>provision of patient samples to underpin research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CRACK-IT consortium</gtr:description><gtr:id>E49504E3-38E8-465F-B4C9-AA57A0F2B1A7</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:partnerContribution>all active contributors to researcher and academic input</gtr:partnerContribution><gtr:piContribution>consortium working on safety assessment</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts Institute of Technology (MIT)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>MIT (Asha Patel, E-term)</gtr:description><gtr:id>D8128C3F-7464-4297-8BD1-27D8142B8C7C</gtr:id><gtr:impact>E-Term Fellowship and sabbatical</gtr:impact><gtr:partnerContribution>E-Term Fellowship and sabbatical</gtr:partnerContribution><gtr:piContribution>E-Term Fellowship and sabbatical</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technion - Israel Institute of Technology</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:description>BIRAX interactions (Mummery, Gepstein)</gtr:description><gtr:id>5055ADF8-04B5-497C-B227-6BDDB3B87926</gtr:id><gtr:impact>Early stage at present</gtr:impact><gtr:partnerContribution>Skills in progenitor cell biology and cell transplantation in vivo</gtr:partnerContribution><gtr:piContribution>New partnership between three labs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pluriomics BV</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>CRACK-IT consortium</gtr:description><gtr:id>6ACA694D-EDE1-4781-B7C5-96105181CFBF</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:partnerContribution>all active contributors to researcher and academic input</gtr:partnerContribution><gtr:piContribution>consortium working on safety assessment</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Genome editing (Skarnes)</gtr:description><gtr:id>0CAA5316-313D-4DB0-9FB3-F771879871DE</gtr:id><gtr:impact>Attracted several new grants of value &amp;pound;2m, introduced new skills to the team, leading to new national / international collaborations</gtr:impact><gtr:partnerContribution>Carrying out the research and intellectual input</gtr:partnerContribution><gtr:piContribution>Skills exchange and training for staff in Nottingham</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Media (as a channel to the public)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C7AF8F3C-EE99-4E16-8E4F-908E6D155037</gtr:id><gtr:impact>- Provision of short articles to magazines such as BioWorld International, BBSRC business, Hospital Solutions - Interview with newspapers, such as Daily Mail, Telegraph etc organised through the Science Media Centre in London - Interviewed and filmed by BBC Scotland 6 O'clock news and BBC / ITV local news stations

Increased public perception and acceptance of the importance of stem cells. Increased application rates from PhD students to our unit</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BHF news advert / article</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9A6A61A6-0B82-4B49-BBBF-460F9188D1FC</gtr:id><gtr:impact>Advertising in national newspaper

to early to tell but part of BHF effort to continually raise funds</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog in Huffington post</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DF8CB1C4-DEAA-4F76-B6C8-316CF2B2B234</gtr:id><gtr:impact>Blog in Huffington Post which promoted new grant - global reach</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.huffingtonpost.co.uk/simon-gillespie/valentines-day_b_6669914.html?utm_hp_ref=science</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SkyNews</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9FD28B28-A863-4CC0-816F-F50D281AD177</gtr:id><gtr:impact>Watched by 13 million people

interest in research group</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nottingham press release (new biomaterials)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7E9D1C7C-BEBD-4937-9275-A6910D61EF2F</gtr:id><gtr:impact>nottingham press release on new publication. Led to additional funding and interaction</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.nottingham.ac.uk/news/pressreleases/2015/july/new-material-forges-the-way-for-stem-cell-factories.aspx</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public engagement day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F96C83D1-9960-4F07-811E-78D791617DD7</gtr:id><gtr:impact>250 members of the public attended the British Society for Gene Therapy public day in Brighton

active engagement and enthusiasm from members of the public</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BHF Visit Outreach for Sorrel Bunting (Nov 2016)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D9281F5E-E4DB-4293-9527-8324E8DFC953</gtr:id><gtr:impact>Group of 20 workers from BHF, including shop-runners, fund raisers, office workers</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC radio Nottingham (Heart-light)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DD44FC1C-9DAA-4A8A-AF27-95427C091E93</gtr:id><gtr:impact>Public engaged on new research grant</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BHF public information booklet on research</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>398F3890-EBF2-4785-8131-196C1E034B34</gtr:id><gtr:impact>British people with interest in heart disease engaged

to early to be determined but acts as part of continual BHF effort to raise funds</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nottingham press release (EPSRC ?6.5m project)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>663E6913-F160-429B-82B4-28D416E58D39</gtr:id><gtr:impact>Press release leading to new interactions</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.nottingham.ac.uk/news/pressreleases/2015/august/3d-vision-for-the-next-generation-of-biomaterials.aspx</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nottingham press release (heart light)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C78F2E43-2631-4B0B-97A0-B2CBB45C989E</gtr:id><gtr:impact>Press release on new grant</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.nottingham.ac.uk/news/pressreleases/2015/february/light-sensitive-proteins-could-help-mend-our-broken-hearts.aspx</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC News</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8EF70D5C-945D-431E-8DFE-5FEC5146E178</gtr:id><gtr:impact>more interest in lab / education

interest in lab / education</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited conference presentation during 2016-2017 reporting period</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FF8A3E5E-ED7A-44B5-B150-591F69EE80A4</gtr:id><gtr:impact>Presented at &amp;gt;20 international conferences in Europe, Middle East, Asia and USA, each having 50 to 500 delegates from professional academic, public, media, patient and industry</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>observer</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0DB0B528-FBCE-4B26-8196-F61D49717438</gtr:id><gtr:impact>Interview with Observer on hiPSC-based cardiovascular work

national press and engagement with public</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>public engagement day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>20CC6F6B-99BD-4684-82D2-7577AA7F1F13</gtr:id><gtr:impact>The engagement day was attended by approx 250 members of the public

good attendance and feedback will mean the event will be run again in 2013.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC East Midlands Today - BHF education on heart disease</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>065C0C96-72FB-4D65-A6B4-4D063F8A98BF</gtr:id><gtr:impact>Interview with BBC East Midlands Today to educate on importance for research for heart disease</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Observer &amp; Guardian on Sunday 2014</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C50517BF-D9F5-48C3-AE2F-0F87985F34D4</gtr:id><gtr:impact>Description of research to National newspapers

follow up enquiries and public engagement</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Channel 4</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>431296A0-8519-4E17-A154-066BE2CB8540</gtr:id><gtr:impact>Featured on channel 4 documentary

disseminated to wider public</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BHF - Welcome booklet imaging (Sorrel Bunting Oct 2016)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7B3D7BA8-D839-44E6-B4C9-C030BB122BDE</gtr:id><gtr:impact>Information booklet commissioned by BHF and Wellcome Trust to support research against cardiovascular disease</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>475000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Programme Grant (2 pilot with Sian Harding)</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>RG/11/19/29264</gtr:fundingRef><gtr:id>3BF871D7-034F-4F25-B99F-D84BA4CF8BE4</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC IPA</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>B0CC2DC7-D4C3-4609-AA9C-00F8ECF1EA83</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>epsrc DTG (Asha)</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>9DCE1505-18A3-4508-9822-20C4E644D0B1</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Asha E-term fellowship</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>C3F244C7-6159-44F9-A1E7-886C8FB2C695</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SC4SM cardiomyocyte call</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Stem Cells for Safer Medicines (SC4SM)</gtr:fundingOrg><gtr:id>2C2C5D94-D1D2-4761-BAC0-C2A7DDBCBA2C</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Int studentship - spandan</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>University of Nottingham</gtr:fundingOrg><gtr:id>61C5DE05-7CE7-4B08-9978-5870BF76511A</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? BHF Programme Grant RG/15/6/31436: Predicting anti-arrhythmic drug efficacy from the divergent molecular basis of RyR2 dysfunction in genetic arrhythmia syndromes</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>RG/15/6/31436</gtr:fundingRef><gtr:id>08EE0815-60F4-4D5C-953E-3704246C58A6</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>67000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? EPSRC Impact Accelerator Award. A Strategic Partnership with the Australian Cooperative Research Centre for Cell Therapy Manufacturing (CRC-CTM) to Commercialise Stem Cell Culture Polymers</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>n/a</gtr:fundingRef><gtr:id>F0DA4404-B3CA-494E-ACBA-9AF2F9AE58F1</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>189000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF LQTS grant (Elena)</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>B4C04C24-A417-4BB7-BF30-3F3D7DC97BCC</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>36000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMDA</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>East Midlands Development Agency (EMDA)</gtr:fundingOrg><gtr:id>8B9AAD4B-659B-418E-A44A-5EA521558D53</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>147000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Heart Res UK (Divya)</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Heart Research UK</gtr:fundingOrg><gtr:fundingRef>TRP01/12</gtr:fundingRef><gtr:id>87830E4A-3110-4359-ADAC-141B4F66DDF3</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? BHF Special Project no. SP/15/9/31605. &amp;quot;Coupling gene targeted reporters with fully automated compound library screening to mature hPSC-cardiomyocytes&amp;quot;.</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>SP/15/9/31605</gtr:fundingRef><gtr:id>E34AC82C-9D30-4B2F-93DC-6EAD6413CC71</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? BIRAX grant 04BX14CDLG. Gene targeted optogenetics in hPSC-cardiovascular cells for transplantation into animal models of heart dysfunction. 1.9.15-31.8.18. &amp;pound;400K</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>British Council</gtr:fundingOrg><gtr:fundingRef>04BX14CDLG</gtr:fundingRef><gtr:id>468375E0-BE86-4F8B-90EE-C70AAB464DD9</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC 'Future-Proof' Synthetic Surfaces</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/H045384/1</gtr:fundingRef><gtr:id>AAD0A458-377E-4FD8-A77D-07246E1DB131</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? EPSRC Programme Grant EP/N006615/1: 'Next Generation Biomaterials Discovery'. PI: Morgan Alexander. Multiple Co-Is. 1.10.15-30.9.20. &amp;pound;6.6m</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/N006615/1</gtr:fundingRef><gtr:id>9E605BA4-8AEA-44DF-9F4E-EB3A8015743A</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3Rs-CRACK-IT phase 2</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>53240DED-69F2-4D63-914C-6C831840075C</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5259190</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EP/H028277/1 EPSRC Centre for Innovative Manufacturing in Regenerative Medicine</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/H028277/1</gtr:fundingRef><gtr:id>CF2B88A9-1C33-4916-A354-5CF2A4473BB4</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>714000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC capital equipment</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L012618/1</gtr:fundingRef><gtr:id>1DA50C9E-234E-4836-AC63-ED4EE4CAFB31</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>515000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3Rs main panel (Viola)</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:fundingRef>NC/K000225/1</gtr:fundingRef><gtr:id>03E1F4C7-5B02-4A1F-894B-B37B1B0CA28C</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF MyoD grant</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>PG/14/59/31000</gtr:fundingRef><gtr:id>51D8450D-412A-48AA-8FB1-BD9C0E14BFDA</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>602000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University of Nottingham Strategic Development Fund &amp;quot;Nottingham Regenerative Medicine Centre&amp;quot; 1.1.15-31.12.18. &amp;pound;602,140 (PI)</gtr:description><gtr:end>2020-10-02</gtr:end><gtr:fundingOrg>University of Nottingham</gtr:fundingOrg><gtr:fundingRef>n/a</gtr:fundingRef><gtr:id>44AC2291-2625-4136-BFE3-4B8A51274ED5</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Centre for Regen Med</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>P47352/</gtr:fundingRef><gtr:id>5651E34A-3AA2-403E-9B29-77D789FB66BB</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1125000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF programme 2014-17</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>710AE5EC-F85A-4800-98FB-FDD0491EC02F</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>115000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC equip - seahorse</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>E723C83A-CF25-4CEE-88CB-56A49FF40C44</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU - dave</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:id>AF278190-FA6C-40E4-AD20-A2849030FF91</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? MRC grant MR/M017354/1: MICA: Development of Metrics and Quality Standards for Scale up of Human Pluripotent Stem Cells. 1.5.15-30.4.17 &amp;pound;1.</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M017354/1</gtr:fundingRef><gtr:id>198D2CBD-7636-45AE-873D-9460CA74ADF5</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3Rs-CRACK-IT phase 1</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>57D080E6-30E3-4E56-AFDA-99E5EC9D7FDA</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>optical spectra for cardiomyocytes using Raman microspectroscopy defined</gtr:description><gtr:id>25B303C8-4E2D-4D75-839A-94C0C014EAE2</gtr:id><gtr:impact>linking into partners within the Bioprocess Research Industry Club</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:patentId>GB1018628.6</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Raman</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>This invention relates to transduction of cargo molecules into living cells, such as protein transduction, in particular a delivery molecule for transduction of a cargo into a cell comprising: a cargo-binding molecule and/or a cargo; a glycosaminoglycan (GAG) binding element, which is capable of binding to GAG on the surface of the cell; and a protein transduction domain. Methods of transduction, methods of producing or modifying cargo for transduction, delivery molecules for transduction and methods of treatment using transduction, or using transduced cells are also provided.</gtr:description><gtr:id>ED0AC114-D56B-4283-830B-814E81BA0E22</gtr:id><gtr:impact>Scientific development with view to licensing.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>WO2015092417</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>GET system with James &amp;amp; Kevin</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Patent filed to cover new synthetic substrate to culture human embryonic stem cells</gtr:description><gtr:id>F3CBDBEC-9FCB-4C65-9530-7A04EC83BA4B</gtr:id><gtr:impact>Negotiations with major plasticware companies in progress through Nottingham's tech trasnfer office</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:protection>Protection not required</gtr:protection><gtr:title>New synthetic culture surfaces for human embryonic stem cells</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>GTAC</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6EF8FDC8-6452-4991-B713-34EB9FCFE41B</gtr:id><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EU Stem Cell Patents</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A5613065-AF90-48F2-BE93-5B070726D7B7</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NC3Rs policy document on regenerative medicine (Kevin Shakesheff 2015)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>735E2205-4CBB-4723-BB52-417001635151</gtr:id><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Masters course</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>0B0DD7EE-EE95-4FD7-BBDE-40207FE3DF93</gtr:id><gtr:impact>masters levels training in stem cell technologies</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>hiPSC lines carrying mutations in long QT syndrome genes</gtr:description><gtr:id>11AC192E-8931-46C0-A04C-47ABE51DF5CC</gtr:id><gtr:impact>1. Braam SR, Tertoolen L, Casini S, Matsa E, Lu HR, Teisman A, Passier R, Denning C, Gallacher DJ, Towart R, Mummery CL. (2012) Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes. Stem Cell Research. 10(1):48-56. PMID: 23089628</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>hiPSC lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>http://europepmc.org/abstract/MED/23089628</gtr:url><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>genome editing techniques and cell lines</gtr:description><gtr:id>D02FDE13-CB6C-4D9C-8870-F32139B8219B</gtr:id><gtr:impact>developing UK and EU portfolio of research tools and assisting collaborations / grants</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>genome editing</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C75B605A-AD8C-4831-A1AA-F347D064DDFA"><gtr:id>C75B605A-AD8C-4831-A1AA-F347D064DDFA</gtr:id><gtr:title>Chemically diverse polymer microarrays and high throughput surface characterisation: a method for discovery of materials for stem cell culture?Electronic supplementary information (ESI) available. See DOI: 10.1039/c4bm00054dClick here for additional data file.</gtr:title><gtr:parentPublicationTitle>Biomaterials science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/71778760bcfbaedc02a6e2939f7135ca"><gtr:id>71778760bcfbaedc02a6e2939f7135ca</gtr:id><gtr:otherNames>Celiz AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2047-4830</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/32B2032A-8162-483C-BB75-5DCD99137BC1"><gtr:id>32B2032A-8162-483C-BB75-5DCD99137BC1</gtr:id><gtr:title>In vitro uses of human pluripotent stem cell-derived cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>Journal of cardiovascular translational research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c737bf77ff2d19310dc6d3e68481b0fd"><gtr:id>c737bf77ff2d19310dc6d3e68481b0fd</gtr:id><gtr:otherNames>Matsa E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1937-5387</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/58050DCD-1F4F-4DF7-9ED3-F6DDDCF0C0ED"><gtr:id>58050DCD-1F4F-4DF7-9ED3-F6DDDCF0C0ED</gtr:id><gtr:title>Rapid micropatterning of cell lines and human pluripotent stem cells on elastomeric membranes.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87660c95d65a3011d13d00df19cbec1f"><gtr:id>87660c95d65a3011d13d00df19cbec1f</gtr:id><gtr:otherNames>Paik I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/63530B8B-C86D-4095-884B-49B996B46EA3"><gtr:id>63530B8B-C86D-4095-884B-49B996B46EA3</gtr:id><gtr:title>Small molecule absorption by PDMS in the context of drug response bioassays.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4fd58851f705a631b75ed1ceded0e823"><gtr:id>4fd58851f705a631b75ed1ceded0e823</gtr:id><gtr:otherNames>van Meer BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9D22B5D1-8392-4173-B517-375202AAAA75"><gtr:id>9D22B5D1-8392-4173-B517-375202AAAA75</gtr:id><gtr:title>Exon skipping and gene transfer restore dystrophin expression in hiPSC-cardiomyocytes harbouring DMD mutations.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d0a82c1753617d519e42ca31d6631d0a"><gtr:id>d0a82c1753617d519e42ca31d6631d0a</gtr:id><gtr:otherNames>Dick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F5704986-836F-433A-8F56-B4D7EAE58119"><gtr:id>F5704986-836F-433A-8F56-B4D7EAE58119</gtr:id><gtr:title>Noninvasive detection and imaging of molecular markers in live cardiomyocytes derived from human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9f7d7c666e2a413306c117639166665b"><gtr:id>9f7d7c666e2a413306c117639166665b</gtr:id><gtr:otherNames>Pascut FC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2138FF38-4AE1-470E-AC60-BD445E693995"><gtr:id>2138FF38-4AE1-470E-AC60-BD445E693995</gtr:id><gtr:title>Identification of polymer surface adsorbed proteins implicated in pluripotent human embryonic stem cell expansion.</gtr:title><gtr:parentPublicationTitle>Biomaterials science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/12624f7c7748d454dbff9720d6c307a4"><gtr:id>12624f7c7748d454dbff9720d6c307a4</gtr:id><gtr:otherNames>Hammad M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2047-4830</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/398C94F6-596B-4A12-8A49-C0BA9E1702BA"><gtr:id>398C94F6-596B-4A12-8A49-C0BA9E1702BA</gtr:id><gtr:title>Highly efficient delivery of functional cargoes by the synergistic effect of GAG binding motifs and cell-penetrating peptides.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/774adde14d69c12426f5b7e4aac46b56"><gtr:id>774adde14d69c12426f5b7e4aac46b56</gtr:id><gtr:otherNames>Dixon JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/97FF1287-02D0-4CF0-9C52-E73A73A9825B"><gtr:id>97FF1287-02D0-4CF0-9C52-E73A73A9825B</gtr:id><gtr:title>Materials for stem cell factories of the future.</gtr:title><gtr:parentPublicationTitle>Nature materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/71778760bcfbaedc02a6e2939f7135ca"><gtr:id>71778760bcfbaedc02a6e2939f7135ca</gtr:id><gtr:otherNames>Celiz AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1476-1122</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E0E88E4-85F7-4B27-87D8-CCCB68D35DF4"><gtr:id>1E0E88E4-85F7-4B27-87D8-CCCB68D35DF4</gtr:id><gtr:title>Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/774adde14d69c12426f5b7e4aac46b56"><gtr:id>774adde14d69c12426f5b7e4aac46b56</gtr:id><gtr:otherNames>Dixon JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/86506380-2DB8-4447-8FD3-65294A813846"><gtr:id>86506380-2DB8-4447-8FD3-65294A813846</gtr:id><gtr:title>Derivation and characterisation of the human embryonic stem cell lines, NOTT1 and NOTT2.</gtr:title><gtr:parentPublicationTitle>In vitro cellular &amp; developmental biology. Animal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/39e2fb8c5f522f60194815ba57656b6d"><gtr:id>39e2fb8c5f522f60194815ba57656b6d</gtr:id><gtr:otherNames>Priddle H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1071-2690</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E85E28B1-7019-4581-8058-0DDF655B6F4A"><gtr:id>E85E28B1-7019-4581-8058-0DDF655B6F4A</gtr:id><gtr:title>Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c737bf77ff2d19310dc6d3e68481b0fd"><gtr:id>c737bf77ff2d19310dc6d3e68481b0fd</gtr:id><gtr:otherNames>Matsa E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7AD6FFF7-9C8F-4F1A-87DA-59DF3A0914B8"><gtr:id>7AD6FFF7-9C8F-4F1A-87DA-59DF3A0914B8</gtr:id><gtr:title>Aberrant a-adrenergic hypertrophic response in cardiomyocytes from human induced pluripotent cells.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/44f93743e559aafdfa1e2921addae87e"><gtr:id>44f93743e559aafdfa1e2921addae87e</gtr:id><gtr:otherNames>F?ldes G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6F24CD30-2E42-495E-9A3B-9D9BAD138E5D"><gtr:id>6F24CD30-2E42-495E-9A3B-9D9BAD138E5D</gtr:id><gtr:title>Current status of drug screening and disease modelling in human pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/295ffa75c27b1791106e9b65b0baa8fc"><gtr:id>295ffa75c27b1791106e9b65b0baa8fc</gtr:id><gtr:otherNames>Rajamohan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F2221F06-B953-428F-95C0-2F08CF9D7EDA"><gtr:id>F2221F06-B953-428F-95C0-2F08CF9D7EDA</gtr:id><gtr:title>A multielectrode array (MEA) biochip with excimer laserproduced microwell features</gtr:title><gtr:parentPublicationTitle>Circuit World</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/68809d33eb7e2bf2fd3588f99f6fdd33"><gtr:id>68809d33eb7e2bf2fd3588f99f6fdd33</gtr:id><gtr:otherNames>Flaherty O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CB9C5AD0-F394-485B-B8FC-069FC56CA0FB"><gtr:id>CB9C5AD0-F394-485B-B8FC-069FC56CA0FB</gtr:id><gtr:title>High throughput screening for discovery of materials that control stem cell fate</gtr:title><gtr:parentPublicationTitle>Current Opinion in Solid State and Materials Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d87383292ff314baabba8e48b3e9fc3a"><gtr:id>d87383292ff314baabba8e48b3e9fc3a</gtr:id><gtr:otherNames>Patel A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9E4CFAA6-2CDA-42C3-AA90-7F19FA16420E"><gtr:id>9E4CFAA6-2CDA-42C3-AA90-7F19FA16420E</gtr:id><gtr:title>Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1dc533ec61bcb06d365d185e0dabeb1f"><gtr:id>1dc533ec61bcb06d365d185e0dabeb1f</gtr:id><gtr:otherNames>Denning C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9E6B73EF-BC8C-48E0-9D75-ECA7235F15C2"><gtr:id>9E6B73EF-BC8C-48E0-9D75-ECA7235F15C2</gtr:id><gtr:title>Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?</gtr:title><gtr:parentPublicationTitle>Journal of neuromuscular diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/98adbe4c2a1dde13837d93783963d6c0"><gtr:id>98adbe4c2a1dde13837d93783963d6c0</gtr:id><gtr:otherNames>Kalra S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ED295DC3-396E-4FA6-8AD4-2A9A69402531"><gtr:id>ED295DC3-396E-4FA6-8AD4-2A9A69402531</gtr:id><gtr:title>Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c737bf77ff2d19310dc6d3e68481b0fd"><gtr:id>c737bf77ff2d19310dc6d3e68481b0fd</gtr:id><gtr:otherNames>Matsa E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E092FA98-DBB0-4195-8A28-5CA911C7BED5"><gtr:id>E092FA98-DBB0-4195-8A28-5CA911C7BED5</gtr:id><gtr:title>Automated Electrophysiological and Pharmacological Evaluation of Human Pluripotent Stem Cell-Derived Cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/295ffa75c27b1791106e9b65b0baa8fc"><gtr:id>295ffa75c27b1791106e9b65b0baa8fc</gtr:id><gtr:otherNames>Rajamohan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C733FDB7-31C0-44D4-8BBD-E8054A4900DA"><gtr:id>C733FDB7-31C0-44D4-8BBD-E8054A4900DA</gtr:id><gtr:title>5-hydroxymethyl-cytosine enrichment of non-committed cells is not a universal feature of vertebrate development.</gtr:title><gtr:parentPublicationTitle>Epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/554888849f9058347fc5093fe6a0ca4f"><gtr:id>554888849f9058347fc5093fe6a0ca4f</gtr:id><gtr:otherNames>Almeida RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1559-2294</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A751BD01-1D92-46F6-9974-8A8E37454E2A"><gtr:id>A751BD01-1D92-46F6-9974-8A8E37454E2A</gtr:id><gtr:title>Maintenance of pluripotency in human embryonic stem cells cultured on a synthetic substrate in conditioned medium.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/be02904063843eff826855654d7e9247"><gtr:id>be02904063843eff826855654d7e9247</gtr:id><gtr:otherNames>Mahlstedt MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4F3C518B-3615-4801-B5B0-69E699F4ACC0"><gtr:id>4F3C518B-3615-4801-B5B0-69E699F4ACC0</gtr:id><gtr:title>Two new protocols to enhance the production and isolation of human induced pluripotent stem cell lines.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d0a82c1753617d519e42ca31d6631d0a"><gtr:id>d0a82c1753617d519e42ca31d6631d0a</gtr:id><gtr:otherNames>Dick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BE40C251-37AB-4084-91FB-B433DC96C6C1"><gtr:id>BE40C251-37AB-4084-91FB-B433DC96C6C1</gtr:id><gtr:title>Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7f098469dc1dbb18dc75ff4bb9372c1b"><gtr:id>7f098469dc1dbb18dc75ff4bb9372c1b</gtr:id><gtr:otherNames>Goldring C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/985431CF-8BAE-486E-964D-89F101E5120A"><gtr:id>985431CF-8BAE-486E-964D-89F101E5120A</gtr:id><gtr:title>Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/931796f79d84b0eb5d39b13aed61804f"><gtr:id>931796f79d84b0eb5d39b13aed61804f</gtr:id><gtr:otherNames>Braam SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9E07F4FD-BBF5-4DBB-9C25-485F928D8F20"><gtr:id>9E07F4FD-BBF5-4DBB-9C25-485F928D8F20</gtr:id><gtr:title>Discovery of a Novel Polymer for Human Pluripotent Stem Cell Expansion and Multilineage Differentiation.</gtr:title><gtr:parentPublicationTitle>Advanced materials (Deerfield Beach, Fla.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/71778760bcfbaedc02a6e2939f7135ca"><gtr:id>71778760bcfbaedc02a6e2939f7135ca</gtr:id><gtr:otherNames>Celiz AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0935-9648</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CB55E05A-5F7C-4391-AEC4-D8392C81A0AA"><gtr:id>CB55E05A-5F7C-4391-AEC4-D8392C81A0AA</gtr:id><gtr:title>Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ac8dda101d738f96423f3e6d8bd9cce1"><gtr:id>ac8dda101d738f96423f3e6d8bd9cce1</gtr:id><gtr:otherNames>International Stem Cell Initiative</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4244A42F-EEC5-4741-B30B-B9410E35427A"><gtr:id>4244A42F-EEC5-4741-B30B-B9410E35427A</gtr:id><gtr:title>A defined synthetic substrate for serum-free culture of human stem cell derived cardiomyocytes with improved functional maturity identified using combinatorial materials microarrays.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/15f5a65ec20558965fa2d27363b8d946"><gtr:id>15f5a65ec20558965fa2d27363b8d946</gtr:id><gtr:otherNames>Patel AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5C51CCFE-B2B7-4866-929A-D2C334EF2584"><gtr:id>5C51CCFE-B2B7-4866-929A-D2C334EF2584</gtr:id><gtr:title>Toward label-free Raman-activated cell sorting of cardiomyocytes derived from human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Journal of biomedical optics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9f7d7c666e2a413306c117639166665b"><gtr:id>9f7d7c666e2a413306c117639166665b</gtr:id><gtr:otherNames>Pascut FC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1083-3668</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2B1DEABE-A6A1-4468-BE30-4CF04082C1EB"><gtr:id>2B1DEABE-A6A1-4468-BE30-4CF04082C1EB</gtr:id><gtr:title>Scaling human pluripotent stem cell expansion and differentiation: are cell factories becoming a reality?</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3ee80f93fb699e3ce06d44043a7ef99d"><gtr:id>3ee80f93fb699e3ce06d44043a7ef99d</gtr:id><gtr:otherNames>Smith JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5B7196E8-66CB-419F-97EB-DA1EC9595B16"><gtr:id>5B7196E8-66CB-419F-97EB-DA1EC9595B16</gtr:id><gtr:title>Genetic manipulation of human embryonic stem cells in serum and feeder-free media.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/931796f79d84b0eb5d39b13aed61804f"><gtr:id>931796f79d84b0eb5d39b13aed61804f</gtr:id><gtr:otherNames>Braam SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/37BF65F7-B683-4EBB-8D7F-EF58AB9FB86C"><gtr:id>37BF65F7-B683-4EBB-8D7F-EF58AB9FB86C</gtr:id><gtr:title>Directed differentiation of human embryonic stem cells to interrogate the cardiac gene regulatory network.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/774adde14d69c12426f5b7e4aac46b56"><gtr:id>774adde14d69c12426f5b7e4aac46b56</gtr:id><gtr:otherNames>Dixon JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3AE9E7BD-80CD-48F5-B2D2-E6A1DB3A86C9"><gtr:id>3AE9E7BD-80CD-48F5-B2D2-E6A1DB3A86C9</gtr:id><gtr:title>Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d0a82c1753617d519e42ca31d6631d0a"><gtr:id>d0a82c1753617d519e42ca31d6631d0a</gtr:id><gtr:otherNames>Dick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BBCCEED0-48A4-4669-B262-9F8D8508A594"><gtr:id>BBCCEED0-48A4-4669-B262-9F8D8508A594</gtr:id><gtr:title>Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6ba577c6d3ec3aa14281199806ff0d41"><gtr:id>6ba577c6d3ec3aa14281199806ff0d41</gtr:id><gtr:otherNames>Lin B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9DDE57D7-057B-4878-A008-EFE8C5A14C3D"><gtr:id>9DDE57D7-057B-4878-A008-EFE8C5A14C3D</gtr:id><gtr:title>Faster generation of hiPSCs by coupling high-titer lentivirus and column-based positive selection.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d0a82c1753617d519e42ca31d6631d0a"><gtr:id>d0a82c1753617d519e42ca31d6631d0a</gtr:id><gtr:otherNames>Dick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801098</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>